2	7	Hanoi	Hanoi	NNP
7	8	,	,	,
9	12	May	May	NNP
13	15	13	13	CD
16	17	(	(	(
17	20	VNA	VNA	NNP
20	21	)	)	)
22	24	–	--	:
25	32	Vietnam	Vietnam	NNP
33	36	has	have	VBZ
37	45	produced	produce	VBN
46	47	a	a	DT
48	55	variety	variety	NN
56	58	of	of	IN
59	64	drugs	drug	NNS
65	67	to	to	TO
68	75	control	control	VB
76	84	HIV/AIDS	hiv/aids	NN
85	87	in	in	IN
88	96	patients	patient	NNS
97	106	suffering	suffer	VBG
107	111	with	with	IN
112	115	the	the	DT
116	123	disease	disease	NN
123	124	.	.	.

125	130	These	these	DT
131	138	include	include	VBP
139	148	Lamivudin	Lamivudin	NNP
149	154	100mg	100mg	CD
155	158	and	and	CC
159	170	Lamizidivir	Lamizidivir	NNP
171	172	(	(	(
172	181	Lamivudin	Lamivudin	NNP
182	187	150mg	150mg	NN
188	191	and	and	CC
192	201	Zidovudin	Zidovudin	NNP
202	207	300mg	300mg	CD
207	208	)	)	)
208	209	,	,	,
210	219	according	accord	VBG
220	222	to	to	TO
223	226	the	the	DT
227	233	Public	Public	NNP
234	240	Health	Health	NNP
241	249	Ministry	Ministry	NNP
249	250	.	.	.

257	260	The	the	DT
261	270	medicines	medicine	NNS
270	271	,	,	,
272	279	jointly	jointly	RB
280	288	produced	produce	VBN
289	291	by	by	IN
292	295	the	the	DT
296	310	Pharmaceutical	Pharmaceutical	NNP
311	318	Company	Company	NNP
319	322	MST	MST	NNP
323	326	and	and	CC
327	330	the	the	DT
331	345	Pharmaceutical	Pharmaceutical	NNP
346	351	Plant	Plant	NNP
352	355	MST	MST	NNP
356	358	in	in	IN
359	361	Ho	Ho	NNP
362	365	Chi	Chi	NNP
366	370	Minh	Minh	NNP
371	375	City	City	NNP
375	376	,	,	,
377	380	are	be	VBP
381	385	made	make	VBN
386	388	of	of	IN
389	399	Zidovudine	Zidovudine	NNP
400	403	and	and	CC
404	414	Lamivudine	Lamivudine	NNP
415	425	substances	substance	NNS
426	428	of	of	IN
429	432	GMP	GMP	NNP
433	442	standards	standard	NNS
443	451	imported	import	VBN
452	456	from	from	IN
457	460	the	the	DT
461	469	Republic	Republic	NNP
470	472	of	of	IN
473	478	Korea	Korea	NNP
479	482	and	and	CC
483	488	India	India	NNP
488	489	.	.	.

496	499	The	the	DT
500	505	first	first	JJ
506	517	Lamizidivir	Lamizidivir	NNP
518	525	tablets	tablet	NNS
526	530	have	have	VBP
531	535	been	be	VBN
536	540	sold	sell	VBN
541	544	for	for	IN
545	548	VND	VND	NNP
549	555	19,500	19,500	CD
556	557	(	(	(
557	558	$	$	$
558	561	1.2	1.2	CD
561	562	)	)	)
563	568	since	since	IN
569	572	May	May	NNP
573	575	of	of	IN
576	580	this	this	DT
581	585	year	year	NN
585	586	,	,	,
587	592	under	under	IN
593	596	the	the	DT
597	603	permit	permit	NN
604	608	from	from	IN
609	612	the	the	DT
613	620	Vietnam	Vietnam	NNP
621	635	Pharmaceutical	Pharmaceutical	NNP
636	643	Control	Control	NNP
644	654	Department	Department	NNP
654	655	.	.	.

662	665	The	the	DT
666	676	department	department	NN
677	681	said	say	VBD
682	686	that	that	IN
687	689	it	it	PRP
690	694	will	will	MD
695	699	cost	cost	VB
700	701	$	$	$
701	704	600	600	CD
705	708	for	for	IN
709	711	an	an	DT
712	720	HIV/AIDS	HIV/AIDS	NNP
721	728	patient	patient	NN
729	732	per	per	IN
733	737	year	year	NN
738	740	at	at	IN
741	745	this	this	DT
746	750	time	time	NN
750	751	,	,	,
752	755	and	and	CC
756	759	the	the	DT
760	769	following	follow	VBG
770	775	years	year	NNS
776	780	this	this	DT
781	785	cost	cost	NN
786	788	is	be	VBZ
789	797	expected	expect	VBN
798	800	to	to	TO
801	806	stand	stand	VB
807	809	at	at	IN
810	814	just	just	RB
815	816	$	$	$
816	824	400/year	400/year	CD
825	828	for	for	IN
829	832	one	one	CD
833	840	patient	patient	NN
841	843	as	as	IN
844	847	the	the	DT
848	858	production	production	NN
859	861	of	of	IN
862	866	such	such	JJ
867	872	drugs	drug	NNS
873	880	becomes	become	VBZ
881	887	stable	stable	JJ
887	888	.	.	.

895	904	Currently	currently	RB
904	905	,	,	,
906	909	the	the	DT
910	918	producer	producer	NN
919	921	is	be	VBZ
922	926	able	able	JJ
927	929	to	to	TO
930	937	process	process	VB
938	943	about	about	IN
944	946	10	10	CD
947	954	million	million	CD
955	962	tablets	tablet	NNS
963	966	per	per	IN
967	972	month	month	NN
973	975	to	to	TO
976	980	meet	meet	VB
981	984	the	the	DT
985	991	demand	demand	NN
992	995	for	for	IN
996	1004	domestic	domestic	JJ
1005	1016	consumption	consumption	NN
1017	1020	and	and	CC
1021	1027	export	export	NN
1028	1030	as	as	RB
1031	1035	well	well	RB
1035	1036	,	,	,
1037	1046	according	accord	VBG
1047	1049	to	to	TO
1050	1053	the	the	DT
1054	1060	Public	Public	NNP
1061	1067	Health	Health	NNP
1068	1076	Ministry	Ministry	NNP
1076	1077	.	.	.

1078	1080	In	in	IN
1081	1084	the	the	DT
1085	1089	near	near	JJ
1090	1096	future	future	NN
1096	1097	,	,	,
1098	1101	the	the	DT
1102	1110	ministry	ministry	NN
1111	1116	added	add	VBD
1116	1117	,	,	,
1118	1122	more	more	JJR
1123	1128	kinds	kind	NNS
1129	1131	of	of	IN
1132	1136	such	such	JJ
1137	1142	drugs	drug	NNS
1143	1152	including	include	VBG
1153	1164	Nevirappine	Nevirappine	NNP
1164	1165	,	,	,
1166	1174	Afaviren	Afaviren	NNP
1175	1178	and	and	CC
1179	1185	Abavir	Abavir	NNP
1186	1190	will	will	MD
1191	1193	be	be	VB
1194	1203	available	available	JJ
1203	1204	.	.	.

1211	1213	As	as	IN
1214	1216	of	of	IN
1217	1222	March	March	NNP
1222	1223	,	,	,
1224	1228	2002	2002	CD
1228	1229	,	,	,
1230	1236	47,514	47,514	CD
1237	1240	HIV	HIV	NNP
1241	1249	carriers	carrier	NNS
1250	1254	were	be	VBD
1255	1265	discovered	discover	VBN
1266	1272	across	across	IN
1273	1276	the	the	DT
1277	1284	country	country	NN
1284	1285	,	,	,
1286	1290	with	with	IN
1291	1296	6,831	6,831	CD
1297	1307	developing	develop	VBG
1308	1318	full-blown	full-blown	JJ
1319	1323	AIDS	AIDS	NNP
1323	1324	.	.	.

1325	1327	As	as	RB
1328	1332	many	many	JJ
1333	1335	as	as	IN
1336	1341	3,780	3,780	CD
1342	1346	died	die	VBD
1347	1349	of	of	IN
1350	1353	the	the	DT
1354	1361	disease	disease	NN
1361	1362	.	.	.